{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T21:55:38Z","timestamp":1777413338870,"version":"3.51.4"},"reference-count":50,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Future Med. Chem."],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.4155\/fmc.12.17","type":"journal-article","created":{"date-parts":[[2012,3,29]],"date-time":"2012-03-29T14:26:43Z","timestamp":1333031203000},"page":"651-660","source":"Crossref","is-referenced-by-count":29,"title":["Neutrophil Elastase Inhibitors: Recent Advances In The Development Of Mechanism-Based And Nonelectrophilic Inhibitors"],"prefix":"10.1080","volume":"4","author":[{"given":"Peter","family":"Sj\u00f6","sequence":"first","affiliation":[{"name":"Department of Medicinal Chemistry, R&I iMED, AstraZeneca R&D, Pepparedsleden 1, SE-431 83, M\u00f6lndal, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2012,3,29]]},"reference":[{"key":"e_1_3_2_3_1_1","doi-asserted-by":"publisher","DOI":"10.1159\/000320823"},{"key":"e_1_3_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200205001-00018"},{"key":"e_1_3_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1986.tb04521.x"},{"key":"e_1_3_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm020881f"},{"key":"e_1_3_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2011.04.047"},{"key":"e_1_3_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1107\/S0909049507060670"},{"key":"e_1_3_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.1979.0078"},{"key":"e_1_3_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2010.07659.x"},{"key":"e_1_3_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(67)80055-X"},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2003-0139OC"},{"key":"e_1_3_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2007.10.009"},{"key":"e_1_3_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00001a015"},{"key":"e_1_3_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm020881f"},{"key":"e_1_3_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00001a013"},{"key":"e_1_3_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/144.4.875"},{"key":"e_1_3_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2103118"},{"key":"e_1_3_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm0004087"},{"key":"e_1_3_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0896(00)00277-7"},{"key":"e_1_3_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(01)00078-6"},{"key":"e_1_3_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2010.12.033"},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.3109\/14756366.2010.486794"},{"key":"e_1_3_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2009.04.011"},{"key":"e_1_3_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2010.07.071"},{"key":"e_1_3_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm700966p"},{"key":"e_1_3_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.06.053"},{"key":"e_1_3_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0960-894X(96)00455-6"},{"key":"e_1_3_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2011.06.036"},{"key":"e_1_3_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2010.12.008"},{"key":"e_1_3_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2010.06.028"},{"key":"e_1_3_2_3_30_1","unstructured":"Sj\u00f6 P . N-Arylpyridones: A novel class of non-electrophilic inhibitors of human neutrophil elastase. Presented at: 5th Anglo-Swedish Medicinal Chemistry Symposium. \u00c5re Sweden 20\u201323 March 2011."},{"key":"e_1_3_2_3_31_1","unstructured":"Stockley RA SnellN PerrettJ GunawardenaK. Efficacy and safety of AZD9668 an oral neutrophil elastase inhibitor in idiopathic bronchiectasis. Presented at: European Respiratory Society Annual Congress. Barcelona Spain 18\u201322 September 2010."},{"key":"e_1_3_2_3_32_1","doi-asserted-by":"crossref","unstructured":"Elborn JS PerrettJ Forsman-SembK Marks-KonczalikJ GunawardenaKet al. Effect of the oral neutrophil elastase inhibitor AZD9668 in patients with cystic fibrosis. Presented at: 107th Annual Conference of the American Thoracic Society. Denver CO USA. 13\u201318 May 2011.","DOI":"10.1164\/ajrccm-conference.2011.183.1_MeetingAbstracts.A6122"},{"key":"e_1_3_2_3_33_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.111.182139"},{"key":"e_1_3_2_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2007.04.005"},{"key":"e_1_3_2_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(02)00393-1"},{"key":"e_1_3_2_3_36_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm960819g"},{"key":"e_1_3_2_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0896(01)00007-4"},{"key":"e_1_3_2_3_38_1","unstructured":"Ishiyama J ArakiK MiuraM. Pharmacological characterization of AX-9657 a potent and selective neutrophil elastase inhibitor with good lung distribution. Presented at: 237th American Chemical Society National Meeting. Salt Lake City UT USA 22\u201326 March 2009."},{"key":"e_1_3_2_4_2_1","unstructured":"AstraZeneca AB: WO2005026123 (2005)."},{"key":"e_1_3_2_4_3_1","unstructured":"AstraZeneca AB: WO2005026124 (2005)."},{"key":"e_1_3_2_4_4_1","unstructured":"Bayer AG: WO2003053930 (2003)."},{"key":"e_1_3_2_4_5_1","unstructured":"Bayer Schering Pharma AG: WO2010078953 (2010)."},{"key":"e_1_3_2_4_6_1","unstructured":"Bayer Healthcare AG: DE102006031314 (2008)."},{"key":"e_1_3_2_4_7_1","unstructured":"Argenta Discover Ltd: WO2009060203 (2009)."},{"key":"e_1_3_2_4_8_1","unstructured":"AstraZeneca AB:WO2009058076 (2009)."},{"key":"e_1_3_2_4_9_1","unstructured":"AstraZeneca AB: WO2005021512 (2005)."},{"key":"e_1_3_2_4_10_1","unstructured":"AstraZeneca AB: WO2005021509 (2005)."},{"key":"e_1_3_2_4_11_1","unstructured":"AstraZeneca AB: WO2004043924 (2004)."},{"key":"e_1_3_2_4_12_1","unstructured":"AstraZeneca AB: WO2007129963 (2007)."},{"key":"e_1_3_2_4_13_1","doi-asserted-by":"crossref","unstructured":"Argenta Discover Ltd: WO2006082412 (2006).","DOI":"10.3833\/pdr.v2006i77.435"}],"container-title":["Future Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/fmc.12.17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:49:29Z","timestamp":1716493769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/fmc.12.17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,29]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["10.4155\/fmc.12.17"],"URL":"https:\/\/doi.org\/10.4155\/fmc.12.17","relation":{},"ISSN":["1756-8919","1756-8927"],"issn-type":[{"value":"1756-8919","type":"print"},{"value":"1756-8927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,29]]}}}